KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Current Taxes: 2009

Historic Current Taxes for Alnylam Pharmaceuticals (ALNY) over the last 1 years, with Dec 2009 value amounting to $7.9 million.

  • Alnylam Pharmaceuticals' Current Taxes rose 104.94% to $237,000 in Q3 2010 from the same period last year, while for Sep 2010 it was $237,000, marking a year-over-year increase of 104.94%. This contributed to the annual value of $7.9 million for FY2009, which is N/A change from last year.
  • According to the latest figures from FY2009, Alnylam Pharmaceuticals' Current Taxes is $7.9 million.
  • Over the past 5 years, Alnylam Pharmaceuticals' Current Taxes peaked at $7.9 million during FY2009, and registered a low of $7.9 million during FY2009.
  • For the 1-year period, Alnylam Pharmaceuticals' Current Taxes averaged around $7.9 million, with its median value being $7.9 million (2009).